news out
China BioPharma Issues Profile on TheAsianInvestor.com
ISELIN, N.J., May 25, 2006 (BUSINESS WIRE) -- Techedge Inc. (OTCBB:TEDG) announced that China BioPharma, Ltd. has issued a company profile on Chinese investment website The Asian Investor.
Investors can view the company report by going to www.theasianinvestor.com
Peter Wang commented, "The Company is pleased to make this first step in launching our investor awareness campaign for China BioPharma, Ltd., as one of China's largest non-government owned human vaccine production companies. The Company is involved in the research and production of human vaccines for highly contagious diseases such as Bird Flu, EHF, and a number of Influenza viruses."
About China BioPharma
China BioPharma, which owns majority rights to Tianyuan Bio-pharmaceutical Co., Ltd., established in 1989, is one of China's largest non-governmental owned vaccine research manufacturers and is the first in China confirmed to GMP standard. The company's current products consist of vaccines for epidemic hemorrhagic fever (EHF) and influenza with high reputation and market-occupying rate. The vaccines for both epidemic hemorrhagic fever and influenza virus have been awarded the National New Product Prize and National Tech Progress Prize.
